Resistance Profile of Urogenital Mycoplasmas to Antibiotics: Comparative Study between the Mycoplasma IST2 and Mycoplasma IST3 — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Resistance Profile of Urogenital Mycoplasmas to Antibiotics: Comparative Study between the Mycoplasma IST2 and Mycoplasma IST3
Department of Biology, Higher Institute of Medical Technology, Yaounde, Cameroon
,
Department of Environmental Sciences, Higher Institute of Agriculture, Wood, Water and the Environment, University of Bertoua, Belabo, Cameroon
,
Department of Biology, Higher Institute of Medical Technology, Yaounde, Cameroon
,
Department of Biology, Higher Institute of Medical Technology, Yaounde, Cameroon
,
Department of Biology, Higher Institute of Medical Technology, Yaounde, Cameroon
,
Department of Biology, Higher Institute of Medical Technology, Yaounde, Cameroon
,
Department of Biology, Higher Institute of Medical Technology, Yaounde, Cameroon
,
Department of Biology, Higher Institute of Medical Technology, Yaounde, Cameroon
,
Pharmacy Laboratory Galenics and Pharmaceutical Legislation, FMSB, University of Yaoundé 1, Yaounde, Cameroon
,
Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon
,
Institute of Medical Research and Medicinal Plants Studies, Yaounde, Cameroon
1 Department of Biology, Higher Institute of Medical Technology, Yaounde, Cameroon
2 Department of Environmental Sciences, Higher Institute of Agriculture, Wood, Water and the Environment, University of Bertoua, Belabo, Cameroon
3 Department of Biology, Higher Institute of Medical Technology, Yaounde, Cameroon
4 Department of Biology, Higher Institute of Medical Technology, Yaounde, Cameroon
5 Department of Biology, Higher Institute of Medical Technology, Yaounde, Cameroon
6 Department of Biology, Higher Institute of Medical Technology, Yaounde, Cameroon
7 Department of Biology, Higher Institute of Medical Technology, Yaounde, Cameroon
8 Department of Biology, Higher Institute of Medical Technology, Yaounde, Cameroon
9 Pharmacy Laboratory Galenics and Pharmaceutical Legislation, FMSB, University of Yaoundé 1, Yaounde, Cameroon
10 Faculty of Medicine and Pharmaceutical Sciences, University of Douala, Douala, Cameroon
11 Institute of Medical Research and Medicinal Plants Studies, Yaounde, Cameroon
Acquired resistance of mycoplasmas to antibiotics constitutes a major health problem in the world in general and in Africa in particular. Despite the diversity of kits marketed, several of them evaluating the sensitivity of mycoplasmas to antibiotics continue to present resistance, in this case, the Mycoplasma IST2. In order to overcome this resistance, a new kit (Mycoplasma IST3) has been developed in accordance with the new Clinical and Laboratory Standard Institute (CLSI) recommendations. The objective of the study was to determine the resistance profile of urogenital Mycoplasmas to antibiotics using this new kit and to highlight cases of co-infections in comparison with the Mycoplasma IST2. Over a period of four mo nths, one hundred and one (101) samples of urogenital secretions were collected (from sexually active men and women) and analyzed. Culture and antibiotic susceptibility testing were performed in a liquid medium using the Mycoplasma IST2 and Mycoplasma IST3 Tests according to the manufacturer’s recommendations. Among the different samples analyzed, we noted a mycoplasma positivity rate of 71.29% with a predominance of infection in women, i.e. 86.12% compared to men 13.88%. Ureaplasma spp was the most encountered germ with a rate of 62.50% followed by cases of co-infections at 33.33% (Uspp/Mh) and the least encountered was Mycoplasma hominis with a rate of 2.79%. We analyzed 25 samples, among which we had 4 co-infections, simultaneously using the two kits in the same patients. The distribution of cases between the two kits was equivalent. We noted a significant rate of resistance to erythromycin 100% using Mycoplasma IST2. However, no resistance was observed in erythromycin with Mycoplasma IST3. Mycoplasma IST2 also showed resistance to fluoroquinolones, which was not the case for Mycoplasma IST3 which did not show any resistance to fluoroquinolones. Both kits showed resistance to tetracycline. The antibiotic sensitivity test using the Mycoplasma IST3 revealed a high rate of resistance to tetracycline, i.e. 57.14% and 91.67% for Ureaplasma spp and Mycoplasma hominis respectively. Resistance rates to other antibiotics were less than 25%. This study was able to demonstrate that Mycoplasma IST3 constitutes a better therapeutic choice compared to its predecessor Mycoplasma IST2, because it eliminated the biggest shortcoming of its predecessor.
Wang, Q., Li, R., Zheng, L. and Shang, X. (2016) Prevalence and Antimicrobial Susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in Female Outpatients, 2009-2013. Journal of Microbiology , Immunology and Infection , 49, 359-362. https://doi.org/10.1016/j.jmii.2014.06.007
Doctissimo (2023). Les infections à mycoplasmes en gynécologie obstétrique. Doctissimo. https://www.doctissimo.fr/html/sante/encyclopedie/14886-infectionsmycoplasmes.htm
Assob, J.C.N., Kamga, H.L., Nde, P.F., Njunda, A.L., Nsagha, D.S., et al . (2010) Genital Mycoplasmas in Women Attending the Yaounde University Teaching Hospital in Cameroon. Journal of Public Health in Africa , 2, e16.
Gonsu, H.K. (2014) Prevalence of Mycoplasma hominis and Ureaplasma Urealyticum among Women Infected with HIV in Yaoundé-Cameroon. International Journal of Infectious Diseases , 21, 333. https://doi.org/10.1016/j.ijid.2014.03.1108
Pereyre, S., Sirand-Pugnet, P., Beven, L., Charron, A., Renaudin, H., Barré, A., et al . (2009) Life on Arginine for Mycoplasma hominis : Clues from Its Minimal Genome and Comparison with Other Human Urogenital Mycoplasmas. PLOS Genetics , 5, e1000677. https://doi.org/10.1371/journal.pgen.1000677
Masson, E. (2022) Résistance aux antibiotiques chez les mycoplasmes et les chlamydiae. EM-Consulte.
Shepard, M.C., Lunceford, C.D. and Baker, R.L. (1966) T-strain Mycoplasma. Selective Inhibition by Erythromycin in Vitro . Sexually Transmitted Infections , 42, 21-24. https://doi.org/10.1136/sti.42.1.21
Yang, T., Pan, L., Wu, N., Wang, L., Liu, Z., Kong, Y., et al . (2020) Antimicrobial Resistance in Clinical Ureaplasma spp. and Mycoplasma hominis and Structural Mechanisms Underlying Quinolone Resistance. Antimicrobial Agents and Chemotherapy , 64, e02560-19. https://doi.org/10.1128/aac.02560-19
Lendamba, R.W., Mbeang Nguema, P.P., Onanga, R. and Mombo, L. (2022) Determination of the Prevalence of Mycoplasma hominis and Ureaplasma Species in Bacterial Vaginosis Patients in Association with Antibiotic Resistance Profile in Franceville, Gabon. Microbial Pathogenesis , 166, Article ID: 105528. https://doi.org/10.1016/j.micpath.2022.105528
Pereyre, S., Gonzalez, P., de Barbeyrac, B., Darnige, A., Renaudin, H., Charron, A., et al . (2002) Mutations in 23S rRNA Account for Intrinsic Resistance to Macrolides in Mycoplasma hominis and Mycoplasma fermentans and for Acquired Resistance to Macrolides in M. hominis . Antimicrobial Agents and Chemotherapy , 46, 3142-3150. https://doi.org/10.1128/aac.46.10.3142-3150.2002
Zheng, W.W., Zhang, W.J., Cui, D., Nie, Z.C., Ding, B.S., Cheng, J.H., et al . (2020) Examination of Ureaplasma urealyticum and Mycoplasma hominis in 4082 Chinese Patients. Brazilian Journal of Medical and Biological Research , 54, e10099. http://www.scielo.br/j/bjmbr/a/Kxy6sT6wXtpD8QXHSC4Q3vp/?lang=en
(2022) Mycoplasma IST2. BioMérieux France. https://www.biomerieux.fr/diagnostic-clinique/mycoplasma-ist2
(2022) MYCOPLASMA IST 3. BioMérieux France. https://www.biomerieux.fr/diagnostic-clinique/mycoplasma-ist-3
Leli, C., Mencacci, A., Bombaci, J.C., D’Alò, F., Farinelli, S., Vitali, M., et al . (2012) Prevalence and Antimicrobial Susceptibility of Ureaplasma urealyticum and Mycoplasma hominis in a Population of Italian and Immigrant Outpatients. InfezMed , 20, 82-87.
Ahouga Voufo, R., Maïdadi, M.F., Mbah, E.C., Esemu, L.F., Fouodji, H.P., Molu, J.P., et al . (2020) STUDY on the Gender Prevalence and Sensitivity of Urogenital Mycoplasmas to Antibiotics in YAOUNDE, Cameroon. Scientific African , 8, e00372. https://doi.org/10.1016/j.sciaf.2020.e00372
Waites, K.B., Katz, B. and Schelonka, R.L. (2005) Mycoplasmas and Ureaplasmas as Neonatal Pathogens. Clinical Microbiology Reviews , 18, 757-789. https://doi.org/10.1128/cmr.18.4.757-789.2005
Guindo, I. (2022) Profil de résistance aux antibiotiques de Mycoplasma hominis et Ureaplasma urealyticum identifiés chez les femmes à Bamako, Mali. Revue Malienne d ’ Infectiologie et de Microbiologie , 17, 32-37. https://doi.org/10.53597/remim.v17i1.2234
Ag, B., Richard, O., Berthold, B.M., Mabika, A., Jolhy, B., Touré, N., et al . (2020) Prevalence and Antimicrobial Susceptibility Profile of Mycoplasma hominis and Ureaplasma urealyticum in Female Population, Gabon. Journal of Applied Biology & Biotechnology , 8, 28-32.
Tadongfack, T.D., Nitcheu, I.L.S., Keubo, F.R.N., Mutarambirwa, H.D., Tedjieu, R.H., Tatang, C.T., et al . (2020) Epidemiology, Prevalence and Antimicrobial Susceptibility of Sexually Transmitted Mycoplasma hominis and Ureaplasma urealyticum Infections in Dschang, West Cameroon. Microbiology Research Journal International , 30, 19-29. https://doi.org/10.9734/mrji/2020/v30i1130280
Kouassi-Agbessi, T.B., Cablan, A.M., Krizo, A.G., Zinzendorf, N.Y. and Amin, C.N. (2019) Etude de la sensibilité aux antibiotiques des mycoplasmes isolés de spermes à Abidjan. International Journal of Biological and Chemical Sciences , 13, 1558-1564. https://doi.org/10.4314/ijbcs.v13i3.28
Duffy, L.B. (2000) Comparative Potency of Gemifloxacin, New Quinolones, Macrolides, Tetracycline and Clindamycin against Mycoplasma spp. Journal of Antimicrobial Chemotherapy , 45, 29-29. https://doi.org/10.1093/jac/45.suppl_3.29
Bartlett, J.G. (2008) Is Activity against “Atypical” Pathogens Necessary in the Treatment Protocols for Community-Acquired Pneumonia? Issues with Combination Therapy. Clinical Infectious Diseases , 47, S232-S236. https://doi.org/10.1086/591409
Taraskina, A.E., Savicheva, A.M., Akopian, T.A., Soroka, A.E., Momynaliev, K.T. and Govorun, V.M. (2002) Drift of tetM Determinant in Urogenital Microbiocenosis Containing Mycoplasmas during Treatment with a Tetracycline Antibiotic. Bulletin of Experimental Biology and Medicine , 134, 60-63. https://doi.org/10.1023/a:1020664807029
Clegg, A., Passey, M., Yoannes, M. and Michael, A. (1997) High Rates of Genital Mycoplasma Infection in the Highlands of Papua New Guinea Determined Both by Culture and by a Commercial Detection Kit. Journal of Clinical Microbiology , 35, 197-200. https://doi.org/10.1128/jcm.35.1.197-200.1997
Mihai, M., Valentin, N., Bogdan, D., Carmen, C.M., Coralia, B. and Demetra, S. (2011) Antibiotic Susceptibility Profiles of Mycoplasma hominis and Ureaplas ma urealyticum Isolated during a Population-Based Study Concerning Women Infertility in Northeast Romania. Brazilian Journal of Microbiology , 42, 256-260. https://doi.org/10.1590/s1517-83822011000100032
Nda Mefo’o, J.P., Notio, R.F., Nkwele, F.M., Ngondi, G.D., Mengue, E.R., Malabo, E.N., et al . (2023) Antibiotics Resistance of Urogenital Mycoplasma in Sexually Active Women Attending Gynecologic Consultation in Douala (Cameroon). Advances in Microbiology , 13, 559-570. https://doi.org/10.4236/aim.2023.1312036